Literature DB >> 4304839

Effect of cytosine arabinoside 5'-triphosphate on mammalian DNA polymerase.

R L Momparler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4304839     DOI： 10.1016/0006-291x(69)90405-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  12 in total

1.  DNA synthesis involving a complexes form of DNA polymerase I in extracts of Escherichia coli.

Authors:  R W Hendler; M Pereira; R Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.

Authors:  D D Ross; D P Cuddy; N Cohen; D R Hensley
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 3.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

4.  In vitro polyoma DNA synthesis: inhibition by 1-beta-d-arabinofuranosyl CTP.

Authors:  T Hunter; B Francke
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

5.  Cytosine-arabinoside does not inhibit incorporation of 3H-thymidine in herpes simplex virus transformed cells.

Authors:  J Roubal
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

Review 6.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

Review 7.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

8.  Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.

Authors:  Judith E Karp; Brian M Thomas; Jacqueline M Greer; Christopher Sorge; Steven D Gore; Keith W Pratz; B Douglas Smith; Karen S Flatten; Kevin Peterson; Paula Schneider; Karen Mackey; Tomoko Freshwater; Mark J Levis; Michael A McDevitt; Hetty E Carraway; Douglas E Gladstone; Margaret M Showel; Sabine Loechner; David A Parry; Jo Ann Horowitz; Randi Isaacs; Scott H Kaufmann
Journal:  Clin Cancer Res       Date:  2012-10-23       Impact factor: 12.531

9.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.

Authors:  J Zittoun; J Marquet; J C David; D Maniey; R Zittoun
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.